Equities researchers at StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note issued on Friday. The firm set a "sell" rating on the biotechnology company's stock.
Neptune Wellness Solutions Price Performance
NEPT opened at $0.53 on Friday. The stock has a market capitalization of $6.21 million, a price-to-earnings ratio of -0.04 and a beta of 1.75. Neptune Wellness Solutions has a 12 month low of $0.23 and a 12 month high of $19.64. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.87 and a quick ratio of 0.38. The business has a 50-day moving average of $0.62 and a two-hundred day moving average of $1.27.
Get Neptune Wellness Solutions alerts:Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) last released its quarterly earnings data on Friday, December 16th. The biotechnology company reported ($0.79) earnings per share for the quarter. The firm had revenue of $11.99 million during the quarter. Neptune Wellness Solutions had a negative net margin of 149.78% and a negative return on equity of 75.30%. On average, research analysts expect that Neptune Wellness Solutions will post -11.35 earnings per share for the current year.
Hedge Funds Weigh In On Neptune Wellness Solutions
Several hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC lifted its stake in shares of Neptune Wellness Solutions by 257.6% in the 1st quarter. Virtu Financial LLC now owns 554,376 shares of the biotechnology company's stock valued at $123,000 after purchasing an additional 399,362 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Neptune Wellness Solutions by 12.6% in the 3rd quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company's stock valued at $196,000 after purchasing an additional 14,395 shares in the last quarter. Capital Wealth Alliance LLC acquired a new position in Neptune Wellness Solutions during the 2nd quarter worth approximately $57,000. Finally, Citadel Advisors LLC acquired a new position in Neptune Wellness Solutions during the 3rd quarter worth approximately $43,000. 5.07% of the stock is owned by institutional investors and hedge funds.Neptune Wellness Solutions Company Profile
(Get Rating)
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Featured Articles
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.